Market Overview

15 Biggest Mid-Day Gainers For Thursday



  • Aerie Pharmaceuticals Inc (NASDAQ: AERI) shares climbed 55 percent to $32.76 on news about its Phase 3 study of Roclatan having met its primary efficacy endpoint.
  • Net Element International Inc (NASDAQ: NETE) shares surged 41.6 percent to $1.60. Net Element shares have declined 43.50 percent over the past 52 weeks, while the S&P 500 index has gained 7.47 percent in the same period.
  • Caladrius Biosciences Inc (NASDAQ: CLBS) gained 17.5 percent to $5.10 as the company reported a deal to raise $25 million in common equity priced at market without warrants.
  • CoLucid Pharmaceuticals Inc (NASDAQ: CLCD) shares rose 12.3 percent to $26.10 after gaining 4.72 percent on Wednesday.
  • AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) shares gained 10.9 percent to $3.64 after the company disclosed that its investigational product candidate ARX-04 provided solid tolerance level in an open-label Phase three trial for post operative acute pain treatment.
  • Lakeland Industries, Inc. (NASDAQ: LAKE) surged 10.3 percent to $10.35. Lakeland Industries reported Q2 earnings of $0.20 per share on revenue of $22.26 million.
  • bluebird bio Inc (NASDAQ: BLUE) shares rose 6.7 percent to $67.08. Goldman Sachs added bluebird bio to Conviction Buy list.
  • Western Refining, Inc. (NYSE: WNR) gained 5.9 percent to $27.77. JP Morgan upgraded Western Refining from Underweight to Neutral.
  • Teck Resources Ltd (USA) (NYSE: TCK) rose 5.7 percent to $18.26. Morgan Stanley upgraded Teck Resources from Underweight to Equal-weight and raised the price target from $7 to $18.
  • Student Transportation Inc (NASDAQ: STB) shares rose 4.4 percent to $5.74. Student Transportation posted stronger-than-expected results for its fourth quarter on Wednesday.
  • Acacia Research Corp (NASDAQ: ACTG) shares gained 4.1 percent to $6.32. Acacia’s subsidiary, Cellular Communications Equipment, has won $22.1 million in patent infringement case against Apple.
  • Agios Pharmaceuticals Inc (NASDAQ: AGIO) shares rose 3.1 percent to $46.66. Agios Pharmaceuticals priced its 3,370,786 shares offering at $44.50 per share.
  • Xencor Inc (NASDAQ: XNCR) shares gained 3 percent to $24.06 after the company reported the initiation of Phase 1b trial of subcutaneous formulation of XmAb7195.
  • Global Payments Inc (NYSE: GPN) rose 3 percent to $75.69. Goldman Sachs upgraded Global Payments from Sell to Neutral and raised the price target from $80 to $88.
  • Dicks Sporting Goods Inc (NYSE: DKS) shares gained 2.5 percent to $60.09. Oppenheimer upgraded Dicks Sporting from Perform to Outperform.

Posted-In: Mid-Day GainersNews Intraday Update Markets Movers


Related Articles (ACTG + ACRX)

View Comments and Join the Discussion!

U.S. Dollar Index Lower Ahead of Data

McKesson Shares Tumble Amid Report Offices Raided On Drug-Pricing Probe